AI-generated summary
The authors randomized 12 professional male volleyball players to receive light-emitting diode therapy at different doses or a placebo over leg muscles before official matches, then measured blood creatine kinase, a marker of muscle damage. They report that doses of 210 J and 315 J avoided significant CK increases, while placebo and 105 J did not. The study involved a single team and a small sample.
- Participants
- 12
- Who or what was studied
- Professional male volleyball players (one team) during a national championship
- Wavelengths
- 850, 630 nm
- Limits stated in the abstract
- Small sample from a single team, with the study described as a single randomized, double-blind trial and no long-term follow-up reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 130 mW, 80 mW
- Total energy
- 105 J, 210 J, 315 J, 0 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dose, Light-emitting diode, Low-level laser therapy, Placebo-controlled, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.